AMGEN ANNOUNCES 2026 FOURTH QUARTER DIVIDEND
Stocks in this Quantisnow insightHealth Care
Historical context for AMGN
Across the 19 sessions after earlier AMGN headlines, the stock closed higher 9 times and lower 10 times, with a median move of 1.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | AMGN | SPY |
|---|---|---|---|
| Oct 28, 2026 | AMGEN TO PRESENT NEW DATA ACROSS RARE AND OTHER SERIOUS AUTOIMMUNE DISEASES AT ACR CONVERGENCE 2026 | +0.9% | +0.3% |
| Oct 27, 2026 | AMGEN APPOINTS DAVID W. GIBBS TO BOARD OF DIRECTORS | +0.7% | +0.6% |
| Oct 26, 2026 | FDA Approval for PAVBLU issued to AMGEN INCand 1 other headline that session | +1.2% | +0.7% |
| Oct 23, 2026 | FDA Approval for PAVBLU issued to AMGEN INC | -1.8% | -0.5% |
| Oct 21, 2026 | AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026 | -0.1% | +0.5% |
| Oct 20, 2026 | TEZSPIRE® DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS | +3.3% | +0.3% |
Quantisnow market dataNASDAQ
AMGN
Amgen Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 1983
Get push alerts for AMGN
Full AMGN profile on Quantisnow Follow AMGN and get a push notification the moment its next story breaks.